| Literature DB >> 26042201 |
Guey-Ying Liao1, Karine Bouyer2, Anna Kamitakahara2, Niaz Sahibzada3, Chien-Hua Wang2, Michael Rutlin4, Richard B Simerly2, Baoji Xu1.
Abstract
OBJECTIVE: Brain-derived neurotrophic factor (BDNF) is a potent regulator of neuronal development, and the Bdnf gene produces two populations of transcripts with either a short or long 3' untranslated region (3' UTR). Deficiencies in BDNF signaling have been shown to cause severe obesity in humans; however, it remains unknown how BDNF signaling impacts the organization of neuronal circuits that control energy balance.Entities:
Keywords: 3′ UTR, 3′ untranslated region; ARH, arcuate nucleus of the hypothalamus; AgRP neuron; AgRP, agouti-related peptide; BDNF, brain-derived neurotrophic factor; DMH, dorsomedial nucleus of the hypothalamus; DiI, 1,1′-dioctadecyl-3, 3,3′,3′-tetramethylindocarbocyanine perchlorate; Excitatory synapse; Inhibitory synapse; LHA, lateral hypothalamic area; NPY, neuropeptide Y; PBS, phosphate buffer saline; POMC neuron; POMC, proopiomelanocortin; PVH, paraventricular hypothalamic nucleus; PVHlp, lateral part of the PVH; PVHmp, medial parvicellular part of the PVH; PVHmpd, medial parvicellular part of the PVH; PVHpml, lateral magnocellular part of the PVH; PVHpv, periventricular part of the PVH; PVT, paraventricular nucleus of the thalamus; Paraventricular hypothalamus; TrkB; Vgat, vesicular GABA transporter; Vglut2, vesicular glutamate transporter 2; aBNST, anterior bed nucleus of the stria terminalis; pSTAT3, phosphorylated signal transducer and activator of transcription 3; α-MSH, alpha-melanocyte stimulating hormone
Year: 2015 PMID: 26042201 PMCID: PMC4443292 DOI: 10.1016/j.molmet.2015.03.003
Source DB: PubMed Journal: Mol Metab ISSN: 2212-8778 Impact factor: 7.422
Figure 1TrkB-expressing cells in the ARH. Representative confocal images acquired from brain sections of adult TrkB;Ai9/+mice after tamoxifen injection. TrkB positive cells, at different anterior-posterior levels relative to Bregma, were marked by tdTomato in the ARH. White and yellow arrows indicate a few representative TrkB-expressing neurons and astrocytes, respectively. 3V, third ventricle. Scale bar, 50 μm.
Figure 2TrkB-expressing neurons represent a distinct subset of ARH neurons. (A) Representative confocal images showing localization of TrkB and POMC neurons in the ARH of Pomc-hrGFP;TrkB;Ai9/+mice. Arrows denote neurons that express both TrkB and POMC. (B) Representative confocal images showing localization of TrkB and NPY neurons in the ARH of Npy-hrGFP;TrkB;Ai9/+animals. Arrows denote neurons that express both TrkB and NPY. (C) Arcuate Rip-Cre neurons were labeled by tdTomato in Rip-Cre/+;Ai9/+ animals (left panel). No β-galactosidase-expressing neurons were detected in the ARH of Rip-Cre/+;fBZ/+mice (right panel). Scale bar, 50 μm. (D) Quantification of colocalization of TrkB with either POMC or NPY in the ARH.
Figure 3Functional analysis of ARH TrkB neurons. (A) Representative confocal images of brain sections obtained from leptin-treated TrkB;Ai9/+animals, illustrating some TrkB neurons express LepRb, as identified by pSTAT3 immunoreactivity. Arrows denote representative neurons positive for both TrkB and pSTAT3. (B–D) TrkB neurons in the ARH are activated under fasting (C) or re-feeding (D) conditions relative to the normal feeding condition (B). Arrows denote representative neurons positive for both TrkB and c-Fos. Scale bar, 50 μm.
Figure 4Neuronal counts for POMC, NPY, and TrkB neurons in the ARH. (A) Representative images of POMC neurons as revealed by hrGFP immunoreactivity in Pomc-hrGFP mice. (B) Representative images of NPY neurons as revealed by hrGFP immunoreactivity in Npy-hrGFP mice. Scale bar, 50 μm. (C) Representative images of TrkB neurons as revealed by DsRed immunoreactivity in TrkB;Ai9/+animals. (D) Numbers of POMC, NPY, and TrkB neurons in Bdnf (+/+) and Bdnf (k/k) mice.
Figure 5Bdnfmice display impaired axonal projections from the ARH to the PVH. (A–D) Confocal images of DiI-labeled ARH fibers in the PVH of Bdnf (+/+) and Bdnf (k/k) mice at P12. The PVHpv, PVHmpd, and PVHpml subregions of each brain sections were defined and the density of labeled fibers in these regions was measured. (A,C) Representative images of Dil-labeled ARH fibers in the PVH of +/+ and k/k mice. HuC/D staining (green) was used to delineate the morphological boundary of the PVH and Dil-labeled ARH fibers are shown in red. Boxed regions indicate the location of each PVH subregion where fiber density was quantified. 3V, the third ventricle. (B, D) A maximal projection image of +/+ and k/k mice was derived from eight confocal images collected (10× objective) through a total distance of 16 μm in an 80-μm thick section. The scale bar represents 50 μm. (E) Quantification of total fiber length in the PVHpv, PVHmpd, and PVHpml in +/+ (n=4) and k/k (n = 3) mice. **p = 0.005 by unpaired t-test.
Figure 6Impaired development of AgRP-containing projections in Bdnfmice. Immunohistochemical labeling of AgRP was performed in Bdnf (k/k) animals and Bdnf (+/+) littermates on P12. (A,B) Representative images of AgRP projections to the PVHmp in +/+ and k/k animals. Dotted lines illustrate the morphological boundaries of the nucleus. 3V, the third ventricle. Scale bar, 42 μm. Square indicates the location of the region in the PVHmp used for quantification. (D,E) Representative images of AgRP projections to the PVHlp in WT and Bdnf mice. Scale bar, 80 μm. Square indicates the location of the region in the PVHlp used for quantification, further illustrated by representative high magnification images (acquired by using a 63x oil corrected lens) in (F) and (G). Scale bar, 13 μm. (C) Quantification of AgRP fiber density in +/+ (n=7) and k/k (n = 10) mice. Data are expressed as mean ± SEM of fiber density in a defined volume. *p = 0.014 by unpaired t-test.
Figure 7Impaired development of α-MSH-containing projections in Bdnfmice. Immunohistochemical labeling of α-MSH projections was performed in Bdnf (k/k) animals and control Bdnf littermates (+/+) on P12. (A,B) Images of α-MSH innervation of the dorsal (d) and ventral (v) subregions of the DMH in +/+ and k/k animals. Scale bar, 70 μm. Dotted lines illustrate the morphological boundaries of the nucleus and different subregions of the DMH. 3V, the third ventricle. Square shows the location of the region in the DMHv used for quantification, further illustrated by representative high magnification images in (C) and (D). Scale bar, 13 μm. (E) Quantification of α-MSH fiber density in the DMHd and DMHv in +/+ (n=6) and k/k (n = 10) mice. Data are expressed as mean ± SEM of fiber density in a defined volume. *p = 0.029 for DMHd and *p = 0.025 for DMHv, respectively, by unpaired t-test.
Figure 8Excitatory and inhibitory presynaptic inputs onto somas of NPY and POMC neurons in the ARH. (A) Confocal images illustrating excitatory (Vglut2) and inhibitory (Vgat) immunoreactive appositions on the somas of ARH NPY neurons visualized by hrGFP in brain sections obtained from Npy-hrGFP mice. The outlined region identifies volume for quantification and is displayed at higher magnification by individual channel to visualize Vglut2 (blue), Vgat (red), and NPY (green) signals, respectively. 3V, third ventricle. Scale bar, 20 μm. (B,C) Quantitative comparison of Vglut2 and Vgat density on the somas of NPY and POMC neurons between Bdnf (+/+) and Bdnf (k/k) mice. Data are expressed as mean ± SEM of inputs per volume sampled. *p = 0.013 for Vglut2 on NPY neurons and *p = 0.046 for Vglut2 on POMC neurons by unpaired t-test.